Clinical trial

Assessment of Noninvasive Methods to Identify Patients at Risk of Serious…

NCT00399503 · University of Calgary, Other · Completed

Key facts

NCT number NCT00399503
Title Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack
Official title Risk Estimation Following Infarction Noninvasive Evaluation (REFINE)
Lead sponsor University of Calgary, Other
Collaborators Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Canada Alberta Heritage Foundation for Medical Research GE Healthcare Industry Cambridge Heart Inc. Hoffmann-La Roche
Status Completed
Study type Observational
Conditions Myocardial Infarction, Death, Sudden, Cardiac
Intervention type Procedure
Interventions Spectral T Wave Alternans, Modified Moving Average T Wave Alternans, Baroreceptor Sensitivity, Heart Rate Variability, Heart Rate Turbulence, Deceleration Capacity, Signal Averaged ECG
Enrollment 350
Start date Sep 1, 2001
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Nov 15, 2006
Last update posted Jun 14, 2016
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies